Perspective Therapeutics(CATX) - 2025 Q3 - Quarterly Results

Perspective Therapeutics Provides Recent Business Highlights and Reports 1Q 2025 Results SEATTLE – May 12, 2025 – Perspective Therapeutics, Inc. ("Perspective," the "Company," "we," "us," and "our") (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatments for cancers throughout the body, today provided a business update and announced results for the quarter ended March 31, 2025. • First of several clinical updates through mid-2026 accepted for presentation at the 2025 Amer ...